Published in Medical Imaging Law Weekly, November 15th, 2005
Scientists in the United States conducted a study "to retrospectively evaluate the MR imaging features of lymphomatoid granulomatosis in the brain. The study, including retrospective analysis of data, was approved by the institutional review board of the National Cancer Institute and complied with Health Insurance Portability and Accountability Act. All patients gave written informed consent."
"Thirty-one patients with pathologically confirmed lymphomatoid granulomatosis were enrolled in a natural history and treatment study at the National Institutes of Health. Twenty-five...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly